16-May-2025
No headlines found.
Rubicon Organics Announces Appointment of Glen Ibbott as Interim CFO
Globe Newswire (Thu, 15-May 7:00 AM ET)
Exec Edge Launches Research Coverage with Initiation Notes on FLD, CLYM, STKS, REX, ACB
PRNewswire (Thu, 8-May 5:40 PM ET)
PRNewswire (Wed, 30-Apr 7:00 AM ET)
International Star Inc Announces New Engagement of T Bone Capital
ACCESS Newswire (Mon, 28-Apr 7:01 AM ET)
PRNewswire (Tue, 15-Apr 7:00 AM ET)
Aurora Cannabis Recognized for Executive Gender Diversity by The Globe and Mail
PRNewswire (Mon, 31-Mar 7:00 AM ET)
Aurora Cannabis to Speak at the Global Cannabis Regulatory Summit
PRNewswire (Tue, 25-Mar 5:01 PM ET)
Aurora Cannabis Announces Breakthrough Discovery of Powdery Mildew Resistant Cultivars
PRNewswire (Thu, 20-Mar 7:00 AM ET)
Aurora Cannabis Expands Medical Cannabis Pastille Offerings in Australia
PRNewswire (Thu, 20-Feb 5:30 PM ET)
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.
Aurora Cannabis - Common Shares trades on the NASDAQ stock market under the symbol ACB.
As of May 16, 2025, ACB stock price climbed to $5.13 with 1,686,196 million shares trading.
ACB has a beta of 1.19, meaning it tends to be more sensitive to market movements. ACB has a correlation of 0.09 to the broad based SPY ETF.
ACB has a market cap of $281.52 million. This is considered a Small Cap stock.
Last quarter Aurora Cannabis - Common Shares reported $63 million in Revenue and $.41 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.37.
In the last 3 years, ACB traded as high as $31.50 and as low as $2.84.
The top ETF exchange traded funds that ACB belongs to (by Net Assets): MJ, YOLO.
ACB has underperformed the market in the last year with a return of -32.6%, while the SPY ETF gained +13.7%. In the last 3 month period, ACB fell short of the market, returning -18.7%, while SPY returned -2.3%. However, in the most recent 2 weeks ACB has outperformed the stock market by returning +6.0%, while SPY returned +4.8%.
ACB support price is $4.79 and resistance is $5.13 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACB shares will trade within this expected range on the day.